News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
453,139 Results
Type
Article (23718)
Company Profile (168)
Press Release (429253)
Section
Business (144853)
Career Advice (1320)
Deals (25939)
Drug Delivery (99)
Drug Development (54657)
Employer Resources (99)
FDA (10008)
Job Trends (11143)
News (241861)
Policy (23567)
Tag
Academia (1379)
Alliances (38711)
Alzheimer's disease (753)
Approvals (9991)
Artificial intelligence (132)
Bankruptcy (231)
Best Places to Work (8547)
Breast cancer (118)
Cancer (984)
Cardiovascular disease (89)
Career advice (1083)
Cell therapy (169)
Clinical research (44882)
Collaboration (413)
Compensation (205)
COVID-19 (1639)
C-suite (103)
Data (945)
Diabetes (126)
Diagnostics (4032)
Drug pricing (106)
Earnings (52158)
Employer resources (90)
Events (63510)
Executive appointments (378)
FDA (10519)
Funding (308)
Gene therapy (128)
GLP-1 (559)
Government (3292)
Healthcare (12219)
Infectious disease (1714)
Inflammatory bowel disease (86)
Interviews (194)
IPO (10593)
Job creations (2917)
Job search strategy (953)
Layoffs (300)
Legal (5587)
Lung cancer (144)
Manufacturing (185)
Medical device (6259)
Medtech (6262)
Mergers & acquisitions (15548)
Metabolic disorders (408)
Neuroscience (1001)
NextGen: Class of 2025 (4550)
Non-profit (2894)
Northern California (1058)
Obesity (254)
Opinion (196)
Patents (97)
People (44334)
Pharmaceutical (83)
Phase I (13908)
Phase II (19123)
Phase III (15288)
Pipeline (470)
Policy (90)
Postmarket research (1772)
Preclinical (4996)
Radiopharmaceuticals (179)
Rare diseases (197)
Real estate (4763)
Regulatory (15840)
Research institute (1294)
Resumes & cover letters (209)
Southern California (975)
Startups (2489)
United States (10277)
Vaccines (318)
Weight loss (213)
Date
Last 7 days (456)
Last 30 days (1219)
Last 365 days (22855)
2025 (1046)
2024 (23142)
2023 (26054)
2022 (34789)
2021 (37284)
2020 (36952)
2019 (33183)
2018 (25475)
2017 (22728)
2016 (21711)
2015 (24934)
2014 (19367)
2013 (16396)
2012 (17758)
2011 (18357)
2010 (16660)
Location
Africa (539)
Arizona (95)
Asia (29386)
Australia (3897)
California (2438)
Canada (1199)
China (259)
Colorado (129)
Connecticut (127)
Europe (62865)
Florida (372)
Illinois (310)
Indiana (178)
Japan (83)
Maryland (484)
Massachusetts (1945)
Michigan (93)
Minnesota (158)
New Jersey (916)
New York (683)
North Carolina (578)
Northern California (1058)
Ohio (116)
Pennsylvania (616)
South America (801)
Southern California (975)
Texas (384)
Washington State (220)
453,139 Results for "johnson matthey pharma services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Johnson Matthey signs agreement to sell its Medical Device Components business for US$700m
Johnson Matthey Plc (JM) announces that it has signed a definitive agreement to sell 100% of its Medical Device Components business (MDC) to Montagu Private Equity (Montagu) for cash consideration of US$700 million (£550 million) on a cash free debt free basis.
March 20, 2024
·
4 min read
Mergers & acquisitions
Johnson & Johnson Makes Major Neuro Play With $14.6B Intra-Cellular Buyout
Among Intra-Cellular’s neuropsychiatric assets is Caplyta, a pill approved for schizophrenia and bipolar depression and proposed for major depressive disorder.
January 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
January 13, 2025
·
20 min read
Deals
Johnson & Johnson Completes Acquisition of Shockwave Medical
Johnson & Johnson announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson & Johnson and will operate as a business unit within Johnson & Johnson MedTech.
May 31, 2024
·
5 min read
Press Releases
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025
January 2, 2025
·
1 min read
Press Releases
Johnson & Johnson MedTech Announces CE Mark Approval for Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter
January 10, 2025
·
10 min read
Press Releases
Johnson & Johnson’s Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer’s Disease
January 8, 2025
·
7 min read
China
Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty
China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.
January 7, 2025
·
6 min read
·
Annalee Armstrong
Deals
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
Acquisition advances Johnson & Johnson’s leading Dermatology portfolio with opportunity to address significant unmet need in atopic dermatitis (AD).
May 16, 2024
·
8 min read
Press Releases
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
December 10, 2024
·
1 min read
1 of 45,314
Next
